Bianca: Phase II, single-arm, global trial to determine efficacy and safety of tisagenlecleucel in pediatric/young adult (YA) patients (Pts) with relapsed/refractory B-cell non-Hodgkin lymphoma (R/R B-NHL).Véronique Minard‐Colin, Birgit Burkhardt, Jochen Buechner et al.|Journal of Clinical Oncology|2020Cited by 6